Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation

Molecular Endocrinology

Volumn 14, Issue 8, 2000, Pages 1175-1186

  Rycyzyn, M A ^a   Reilly, S C ^a   O'Malley, K ^a   Clevenger, C V ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROLACTIN; RECOMBINANT PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMARY GLAND; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; YEAST;

EID: 0034463072     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.8.0508     Document Type: Article

References (64)

1. Prolactin and growth hormone receptors
2. Prolactin receptor signal transduction in cells of the immune system
3. Immune function of prolactin (PRL) and signal transduction by PRL/GH/cytokine receptors: Specificity, redundancy and lessons from chimaeras
4. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants
5. Prolactin induces rapid phosphorylation and activation of prolactin receptor associated Raf-1 kinase in a T-cell line
6. fyn is associated with prolactin receptor and is activated by prolactin stimulation of T-lymphocytes
7. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line
8. Cytokine receptor signaling
9. Identification of cytoplasmic motifs required for short prolactin receptor internalization
10. Interleukin-2 driven nuclear translocation of prolactin in cloned T-lymphocytes
11. Nuclear translocation of prolactin: Collaboration of tyrosine kinase and protein kinase C activation in rat Nb2 node lymphoma cells
12. Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes
13. Regulation of IL2-driven T-lymphocyte proliferation by prolactin
14. Ubiquitination is required for the retrotranslocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome
15. Accumulating evidence suggests that several AB toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells
16. Surfing on a retrograde wave: How does Shiga toxin reach the endoplasmic reticulum
17. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
18. Receptor-mediated nuclear translocation of growth hormone
19. The alternatively spliced exon of the platelet-derived growth factor A chain encodes a nuclear targeting signal
20. Chromatin binding of epidermal growth factor, nerve growth factor, and platelet-derived growth factor in cells bearing the appropriate surface receptors
21. Preparation and characterization of colloidal gold-insulin complex with binding and biological activities identical to native insulin
22. Ultrastructural evidence for the accumulation of insulin in nuclei of intact 3T3-L1 adipocytes by an insulin-receptor mediated process
23. Immunological demonstration of the accumulation of insulin, but not insulin receptors, in nuclei of insulin-treated cells
24. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells
25. A functional bipartite nuclear localization signal in the cytokine interleukin-5
26. The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro
27. Dual mode a signal transduction by externally added acidic fibroblast growth factor
28. Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization
29. Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2
30. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas
31. Evidence in vivo and in vitro of a role for the pituitary in the growth of malignant lymphomas in Nb rats
32. Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor
33. Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation
34. In situ detection of cyclosporin A: Evidence for nuclear localization of cyclosporine and cyclophilins
35. Human cyclophilin B: A second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence
36. Effects of the immunosuppressive drugs CsA and FK506 on intracellular signailing and gene regulation
37. Molecular mechanisms of the immunosuppressive action of cyclosporin A
38. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA expression
39. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
40. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: One in the presence and one in the absence of CsA
41. p, a T lymphocyte DNA-binding protein that is a target calcineurin and immunosuppressive drugs
42. Calcium signalling T cells stimulated by a cyclophilin B-binding protein
43. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: Roles of calcineurin binding and cellular location
44. Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism
45. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine
46. Antagonism of prolactin binding by cyclosporine A on MCF7 breast tumour cell line
47. Structures of cyclophilin-ligand complexes
48. Cyclophilin A modulates processing of human immunodeficiency virus type 1 p55Gag: Mechanism for antiviral effects of cyclosporin A
49. Protein disulphide isomerase and a lumenal cyclophilin-type peptidyl prolyl cis-trans isomerase are in transient contact with secretory proteins during late stages of translocation
50. Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies
51. Evidence that human isolated cyclophilin B corresponds to a truncated form
52. Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IFR-2) genes are developmentally regulated
53. Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A
54. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
55. The molecular basis for growth hormone-receptor interactions
56. Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen
57. Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function
58. Effects of epidermal growth factor (EGF) and prolactin on EGF receptor cytoskeletal association in mammary epithelial cells
59. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 in induced by growth hormone
60. Mitogenic and binding properties of monoclonal antibodies to the prolactin receptor in Nb2 rat lymphoma cells
61. Interaction trap/two-hybrid system to identify interacting proteins
62. Determination of kinetic constants for peptidyl prolyl cis-trans iosmerases by an improved spectrophotometric assay
63. Cell-free pool of CD14 mediates activation of transcription factor NF-kB by lipopolysaccharide in human endothelial cells
64. Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52